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aBSTRaCT
This study investigated the effect of an antiparasitic ivermectin (IVM) drug on the endocrine reproductive 
hormones of twenty healthy adult 250-350 kg Baladi cows that were 4-7 years of age. The cows were divided 
into two groups (n = 10 each). The first was a control group injected with physiological saline; the second group 
was treated with the recommended therapeutic dose of IVM (0.2 mg/kg, s/c) one day after parturition. Blood 
samples were taken on the 1st, 15th, 30th and 90th day after IVM treatment. The results revealed that IVM injection 
at one day after parturition delayed estrous for up to 3 months (absence of estrous signs and rectal palpation 
revealed no ovarian structures). IVM significantly (P<0.05) decreased serum follicular stimulating hormone 
(FSH), luteinizing hormone (LH) and estradiol for up to 3 months. In addition, IVM significantly (P<0.05) 
increased serum progesterone, prolactin and cortisol for up to 3 months. Further, IVM caused unobservable 
changes in serum testosterone and sex hormones binding globulin. Serum calcium levels significantly increased 
on the 1st day of IVM injection, while serum phosphorus significantly decreased on the15th and 30th day of 
IVM injection. It was concluded that IVM delayed estrous in cows for three months via disturbances in the 
female reproductive hormones and calcium/phosphorus homeostasis. Therefore, it is recommended that IVM 
should not be injected directly after parturition. Furthermore, the increased calcium after IVM indicates that 
an overdose of IVM should not be counteracted by calcium therapy; instead, any other antiallergic preparation 
could be used.
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Introduction
Ivermectin (IVM) belongs to a family of compounds (avermectins, which also 
include abamectin, emamectin, eprinomectin and doramectin) that are produced by the 
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microorganism actinomycete streptomyces avermitilis, which was first isolated from soil 
in Japan (PARADIS, 1986). The structure of IVM is similar to that of macrolide antibiotics, 
but it appears to lack any antibacterial or antifungal activities. IVM was introduced to 
the market in 1981 as a veterinary antiparasitic drug and soon proved to be the most 
effective broad spectrum antiparasitic drug ever developed (WOODWARD, 2011). Five 
years after its introduction, IVM was registered for use in 46 countries and was being 
used worldwide to treat approximately 320 million cattle, 151 million sheep, 21 million 
horses and 5.7 million pigs. In simple-stomached animals, 95 % of oral IVM is absorbed 
(PLUMB, 2002). Its absorption after oral dosing is more rapid than that after subcutaneous 
administration, although there is greater bioavailability after subcutaneous administration. 
IVM concentrates in the liver and body fat (BEASLEY, 1990). It is excreted in the feces 
and has a low degree of liver metabolism. The persistence of the parent compound in 
the body may partly explain the long half-life, which is reported to be 2 to 3 days. Due 
to its rapid and specific antiparasitic and anthelmintic action, IVM was proposed to be 
an agonist for neurotransmitter function. Experimental studies confirmed this hypothesis 
by demonstrating that inhibition occurred via glutamate-gated chloride ion channels 
and invertebrate-specific glutamate-gated anion channels in peripheral neuromuscular 
synapses, thus suppressing nerve impulse conduction (ÕMURA, 2002). IVM interacts 
with these channels, thereby preventing their closure. Consequently, synapse membranes 
become increasingly permeable to chloride ions, which leads to the hyperpolarization of 
the neuronal membrane, and decreases or prevents neuronal transmission. This, in turn, 
leads to paralysis of the somatic muscles, particularly the pharyngeal pump, causing the 
death of the parasite (ARBONA et al., 2010). The γ-aminobutyric acid (GABA)-related 
chloride ion channels, which are present only in nematodes, insects and ticks, are only 
inhibited with greater drug concentrations (TURNER and SCHAEFFER, 1989). The same 
authors revealed that, in mammals, GABA receptors and neurons are found in the central 
nervous system, whereas in arthropods and nematodes, they are located in the peripheral 
nervous system. 
The location of GABA receptors, coupled with the relatively low doses needed, 
ensures that mammals can ingest IVM with a high degree of safety. IVM is effectively 
and widely used against numerous endoparasites and ectoparasites, especially nematodes 
and arthropods (CHACCOUR et al., 2013). However, IVM exhibits a broad spectrum of 
activity against gastrointestinal and lung nematodes and against ectoparasites of clinical 
relevance in domestic animals (SUÁREZ et al., 2013). Two conflicting and inconsistent 
viewpoints about the effects of IVM on animal reproduction are prevalent among 
scientists. Namely, some researchers feel that IVM has dangerous and hazardous effects 
on reproduction (COUSENS et al., 1997). Others feel that IVM can have beneficial effects on 
reproductive efficiency in animals (LANKAS et al., 1989). Due to these conflicting views, 
this study aimed to evaluate the possible deleterious effects of IVM on reproduction and 
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to determine whether these effects were temporary or permanent, neither of which has 
been determined previously.
Materials and methods
Twenty mature Baladi cows, aged 4-7 years and weighing 250-350 kg, were used 
in this study. This study was performed from 15 July 2013 to 15 October 2013. The 
cows were divided randomly into 2 groups, with each group containing 10 animals. The 
first group was a control group and was injected with physiological saline; the second 
was treated with the recommended therapeutic dose of IVM (1 % w/v solution of 
IVM, V.M.D. Ltd, Arendonk, Belgium, 0.2 mg/kg, s/c) one day after parturition. Blood 
samples of 10 mL were collected via jugular venipuncture on the 1st, 15th, 30th and 90th 
days post injection. Sera were harvested via centrifugation at 3,000 rpm for 15 minutes 
and stored at -20 °C until biochemical analysis. Sera were used for the assessment of 
testosterone, estradiol, FSH, LH, prolactin, progesterone, sex hormones binding globulin 
(SHBG), cortisol, calcium and phosphorus. All biochemical parameters were analyzed 
using commercially available kit methods. Unico 2100 UV-Spectrophotometers, 
ELx800 Absorbance Microplate Reader and other laboratory equipment aids were used 
for biochemical analysis. Moreover, each parameter was performed according to the 
instructions of its kit.
statistical analysis. The Student’s t-test (independent sample test) was used to 
compare the treated and control groups. The data were expressed as the means ± standard 
error of means (SEM). The differences were considered statistically significant at P<0.05. 
Results
General signs. The clinical examination revealed absence of estrous signs and rectal 
palpation revealed no ovarian structures up to three months post IVM injection.
serum testosterone and estradiol. Compared to the control group, the serum 
testosterone level in the IVM-treated group was not affected throughout the experiment. 
However, serum estradiol significantly decreased (P<0.05) in concentration by the 15th 
and 30th days and returned to the control value by the 90th day (Table 1).
Table 1. Effects of IVM on serum testosterone and estradiol in Baladi cows post parturition 
Groups Serum testosterone (ng/mL) Serum estradiol (pg/mL)
Control 0.82 ± 0.02a 139 ± 4.66a
Treated 
1st day 0.76 ± 0.04a 135 ± 5.45ab
15th day 0.87 ± 0.01a 87 ± 3.13c
30th day 0.81 ± 0.02a 63 ± 2.89d
90th day 0.85 ± 0.06a 142 ± 5.73a
Means within the same column carrying different letters are significantly different (P<0.05)
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serum Fsh and Lh. Compared with the control animals, the serum FSH level 
significantly decreased (P<0.05; Table 2) by the 15th and 30th days in the IVM-treated 
cows. The serum LH level significantly decreased by the 30th day. Both hormones returned 
to the control level by the 90th day.
Table 2. Effects of IVM on serum FSH and LH in Baladi cows post parturition 
Groups Serum FSH (mIU/mL) Serum LH (mIU/mL)
Control 8.9 ± 1.35a 16.4 ± 2.65b
Treated 
1st day 9.1 ± 0.87a 18.1 ± 3.09a
15th day 7.2 ± 1.41b 16.7 ± 2.76b
30th day 7.4 ± 1.12b 13.2 ± 1.77c
90th day 8.8 ± 0.91a 16.2 ± 3.17b
Means within the same column carrying different letters are significantly different (P<0.05).
serum prolactin and progesterone. Table 3 shows that cows in the IVM-treated group 
had a significant increase in serum prolactin and serum progesterone on the 1st, 15th, and 
30th days compared with the placebo group (P<0.05). The level of progesterone hormone 
returned to normal levels on the 90th day, while the prolactin level was still significantly 
increased (P<0.05) compared with control group.
Table 3. Effects of IVM on serum prolactin and progesterone in Baladi cows post parturition 
Groups Serum prolactin (ng/mL) Serum progesterone (ng/mL)
Control 16.1 ± 2.04c 0.9 ± 0.05c
Treated 
1st day 21.7 ± 3.23b 1.7 ± 0.83b
15th day 22.3 ± 2.66b 3.2 ± 0.58a
30th day 29.7 ± 3.18a 1.9 ± 0.11b
90th day 21.8 ± 1.85b 1.1 ± 0.09c
Means within the same column carrying different letters are significantly different (P<0.05)
Table 4. Effects of IVM on serum SHBG and cortisol in Baladi cows post parturition
Groups SHBG (nmol/L) Cortisol (µg/dL)
Control 69.1 ± 5.74a 7.89 ± 1.36b
Treated 
1st day 68.4 ± 6.67a 13.61 ± 3.78a
15th day 63.2 ± 4.18b 12.99 ± 1.00a
30th day 69.3 ± 8.38a 14.47 ± 2.93a
90th day 68.7 ± 5.89a 9.17 ± 1.62b
Means within the same column carrying different letters are significantly different (P<0.05)
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Changes in serum cortisol level and sex hormones binding globulin. Table 4 shows 
that serum cortisol was significantly (P<0.05) increased on the 1st, 15th and 30th days post 
injection in the IVM-treated group, compared with the control group. However, the sex 
hormones binding globulin showed no changes throughout the experimental period.
Table 5. Effects of IVM on serum calcium and phosphorus in Baladi cows post parturition 
Groups Calcium (mg/dL) Phosphorus (mg/dL)
Control 9.85 ± 0.89b 5.75 ± 0.74a
Treated 
1st day 13.76 ± 1.66a 5.29 ± 1.55a
15th day 10.33 ± 0.90b 2.16 ± 0.05b
30th day 10.19 ± 1.22b 2.86 ± 0.08b
90th day 9.25 ± 1.36b 4.88 ± 0.68a
Means within the same column carrying different letters are significantly different (P<0.05)
serum calcium and phosphorus. Table 5 shows a significant increase in serum calcium 
levels on the 1st day post injection in the IVM-treated group, compared with the control 
group (P<0.05). The serum phosphorus were significantly (P<0.05) decreased on the 15th 
and 30th days following IVM treatment. On the 90th day, both calcium and phosphorus 
returned to the normal control values.
discussion
The effects of IVM on selected reproductive hormones in Baladi cows were studied. 
The current findings in this study demonstrate that serum FSH, LH and estradiol levels 
undergo dramatic changes, as represented by a sharp decrease after IVM injection, but 
return to their normal values on the 90th day following the injection. 
Further, IVM injection significantly increased serum progesterone, prolactin 
and cortisol levels, and these levels returned to control values by the 90th day 
post injection. Serum sex hormones binding globulin and testosterone were not 
affected throughout the experiment. IVM caused disturbances in calcium/phosphorus 
homeostasis, which was reflected in a significantly increased calcium level on the 1st day 
post IVM injection, and significantly decreased the phosphorus level on the 15th and 30th 
days post IVM injection. This effect is due to the high bioavailability of IVM and its long 
duration of action (TOUTAIN et al., 1997). The administration of IVM eventually caused 
significant pathological alterations that primarily affected the genital organs of female 
guinea pigs which may affect their reproductive performance (AL-HIZAB and HASSIEB, 
2010). The effects of IVM on GABA-mediated neural transmission and the ability of 
GABA to suppress gonadotropin secretion combined with drug distribution and clearance 
(CHIU et al., 1990) subsequently suppressed normal ovarian function. In addition, IVM 
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decreased semen parameters and serum testosterone and follicle-stimulating hormone in 
Red Sokoto buck and serum testosterone in Iraqi Awassi ram, respectively (NAOMAN, 
2012). Thus, IVM should be used cautiously in bucks and rams that are meant for breeding 
due to the deleterious effects observed on the animals’ fertility parameters. There was an 
observable increase in serum progesterone level when IVM was administered during the 
breeding season in female camels and ewes, respectively (SERI et al., 2000). The reason for 
the increase in progesterone is not clearly known and may be considered to be either of 
ovarian or adrenal origin (BULMAN and LAMMING, 1978). The hypothalamo-hypophyseal 
negative feedback of progesterone could be responsible for decreased FSH and LH and, 
subsequently, decreased estrogen associated with delayed estrous after IVM injection, as 
observed in the current study. IVM is an irritant and subcutaneous drug that causes pain to 
the animal at the site of injection (BURG et al., 1979). This pain could explain the increased 
serum cortisol level. Nevertheless, MEJÍA et al. (1999) concluded that IVM treatment in 
dairy heifers may increase growth rate during development, advance the onset of ovarian 
function (earlier puberty) and positively affect the yearling pelvic area. The treatment of 
heifers at weaning with IVM increased the number of animals in estrous at the end of the 
feeding period (BAUCK et al., 1992). The same authors anticipated that any improvement 
in reproductive performance would occur strictly as a result of improvements in the body 
weight of heifers. 
A number of studies have been performed investigating the involvement of insulin 
and the IGF family in IVM-induced ovarian activity (YELICH et al., 1996). These studies 
involved the regulation of neuroendocrine events in the hypothalamo-pituitary (MONGET 
and MARTIN, 1997) and at ovarian levels (CHASE et al., 1998). Antiparasitic treatment in 
heifers appears to be associated with early puberty onset and improved fertility (PURVIS 
and WHITTIER, 1996). However, continuous treatment with IVM from birth to puberty 
caused no differences in serum FSH, estradiol, or thyroxine levels between the treated 
and untreated heifers (LACAU-MENGIDO et al., 2000). IVM has no detrimental effect on 
the reproductive performance of ewes during the breeding season (KEISLES et al., 1993), 
which is reflected in the lack of alterations in the interval from PGF2ά-induced luteal 
regression to the onset of estrous between IVM- and control-treated ewes. WHITTIER 
et al. (1999) observed no LH variation in response to IVM treatment despite observing 
increased follicular development. 
This discrepancy may be attributed to the species, age, seasonal variations of the 
ovarian activity or breed variation of animals used, and the dosage of drugs administered 
(PAUL and TRANQUILLI, 1986). Climatic variations may also be a factor responsible for 
these differences.
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Conclusion
The results obtained in this study provide convincing evidence that strongly support 
producers’ concern about the detrimental effect of IVM on fertility. IVM delayed estrous 
in cows for three months (absence of estrous signs and rectal palpation revealed no ovarian 
structures) via disturbances in female reproductive hormones and calcium/phosphorus 
homeostasis. Thus, IVM should not be injected directly after parturition. Furthermore, the 
increased calcium level observed post IVM injection indicates that an overdose of IVM 
should not be counteracted using calcium therapy. Any other antiallergic preparations 
should be applied instead. The mechanisms by which IVM treatment influences the 
female reproductive hormones need to be ascertained. We suggest that further studies are 
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Sažetak 
Kod 20 zdravih i odraslih krava baladi pasmine, čija se tjelesna masa kretala od 250 do 350 kg, a dob od 4 
do 7 godina, istražen je učinak antiparazitika ivermektina (IVM) na spolne hormone. Krave su bile podijeljene 
u dvije skupine (10 u svakoj skupini). Prvoj, kontrolnoj skupini bila je prvog dana nakon teljenja ubrizgana 
fiziološka otopina soli natrijeva klorida, a drugoj preporučena terapijska doza ivermektina (0,2 mg/kg, s/c). 
Uzorci krvi bili su prikupljeni 1., 15., 30. i 90. dana nakon primjene ivermektina. Rezultati su pokazali da je 
njegova primjena dan nakon teljenja dovela do odgode estrusa u trajanju do 3 mjeseca (izostali znakovi estrusa 
i strukture pri rektalnoj palpaciji jajnika). U razdoblju od 3 mjeseca došlo je do signifikantnog (P<0,05) sniženja 
razine folikulostimulirajućeg hormona (FSH), luteinizirajućeg hormona (LH) i estradiola u serumu. U istom 
razdoblju ivermektin je uzrokovao signifikantan (P<0,05) porast serumskog progesterona, prolaktina i kortizola, 
te slabo uočljive promjene razine serumskog testosterona i globulina koji veže spolne hormone. Razina kalcija u 
serumu značajno je porasla 1. dana, dok je razina fosfora u serumu signifikantno pala 15. i 30. dana od primjene 
ivermektina. Zaključeno je da ivermektin odgađa estrus kod krava u trajanju od 3 mjeseca putem narušavanja 
ravnoteže spolnih hormona odnosno poremećaja homeostaze kalcija i fosfora. Zbog toga se ne preporučuje 
njegovo davanje netom nakon teljenja. Nadalje, povišena razina kalcija nakon njegove prekomjerne primjene 
ne bi se smjela suzbijati davanjem kalcija, već upotrebom drugih antialergijskih pripravaka.
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